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Replicon systems have been useful to study mechanisms of translation and replication of flavivirus
RNAs. In this study, we constructed a dengue virus 4 replicon encoding a Renilla luciferase (Rluc)
reporter, and six single-residue substitution mutants were generated: L128F and S158P in the
non-structural protein (NS) 3 protease domain gene, and N96I, N390A, K437R and M805I in the
NS5 gene. The effects of these substitutions on viral RNA translation and/or replication were
examined by measuring Rluc activities in wild-type and mutant replicon RNA-transfected Vero cells
incubated at 35, 37 and 39 6C. Our results show that none of the mutations affected translation
of replicon RNAs; however, L128F and S158P of NS3 at 39 6C, and N96I of NS5 at 37 and
39 6C, presented temperature-sensitive (ts) phenotypes for replication. Furthermore, using in vitro
methyltransferase assays, we identified that the N96I mutation in NS5 exhibited a ts phenotype for
N7-methylation, but not for 29-O-methylation.
The four serotypes of dengue virus (DENV1–4), mosquito-
borne members of the family Flaviviridae, cause wide-
spread human diseases ranging from dengue fever to the
more severe forms, dengue haemorrhagic fever and dengue
shock syndrome (Gubler, 2006; Halstead, 2008). DENV
causes an estimated 50–100 million cases of dengue fever,
of which 1% result in severe forms. Currently, there is no
vaccine or antiviral drug to treat DENV infections (Gubler,
2006; Hatch et al., 2008; Kyle & Harris, 2008).
DENV has an ssRNA genome of positive polarity,
approximately 11 kilobases in length, with a 59 cap but
no poly(A) tail at the 39 end (reviewed by Lindenbach &
Rice, 2003). The single long ORF of the viral RNA encodes
a polyprotein that is processed co- and post-translationally
by both cellular signal peptidase and viral serine protease in
the endoplasmic reticulum (ER) membrane into three
structural proteins, capsid (C), precursor membrane (prM)
and envelope (E), and seven non-structural (NS) proteins:
NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 (reviewed
by Beasley, 2005; Harris et al., 2006).
Flavivirus NS proteins play an essential role in viral RNA
translation and replication. Some NS proteins have
multiple functions in the virus life cycle (Miller et al.,
2010; Padmanabhan et al., 2006). The N-terminal 180
residues of NS3, in conjunction with NS2B, function as a
viral protease required for polyprotein processing
(reviewed by Padmanabhan & Strongin, 2010; Sampath &
Padmanabhan, 2009). The NS3 carboxy-terminal region
has conserved motifs found in the ‘D-E-X-H’ family of
RNA helicases (reviewed by Lescar et al., 2008). The
amino-terminal region of NS5 has a 59 RNA methyltrans-
ferase (MTase) activity, which catalyses sequentially the
transfer of a methyl group from S-adenosylmethionine to
the N7 of the 59 guanosine cap (Ray et al., 2006; reviewed
by Davidson, 2009; Dong et al., 2008) and to the 29-OH
moiety of adenosine at the 59 end of the RNA genome
(Egloff et al., 2002). NS5 also has RNA-dependent RNA
polymerase (RdRP) activity (Tan et al., 1996), capable of de
novo synthesis of the minus strand in vitro (Ackermann &
Padmanabhan, 2001), and is required for virus replication
in cultured cells (Khromykh et al., 1998, 1999; reviewed by
Malet et al., 2008; Miller et al., 2010).
Replicons encoding a reporter gene are useful tools for
studying the translation and replication of flaviviruses,
including Kunjin virus (Khromykh & Westaway, 1997),
West Nile virus (WNV) (Shi et al., 2002), yellow fever virus
(Corveretal.,2003;Jonesetal.,2005a),DENV2(Alvarezetal.,
2005; Jones et al.,2 0 0 5 b ;M .I .M .M a n z a n o ,E .D .R e i c h e r t ,
S. L. Alcaraz-Estrada, S. Polo, B. Falgout, W. Kasprzak,
B. A. Shapiro & R. Padmanabhan, unpublished results) and
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knowledge, the construction of a reporter replicon for
DENV4 has not yet been reported.
We sought to construct a DENV4 replicon with Renilla
luciferase (Rluc) reporter to study mechanisms of virus
replication. A DENV4 infectious clone was placed into an
Escherichia coli–yeast shuttle vector to yield the pRS424-
DENV4IC clone by using a previously described method
(Polo et al., 1997). The pRS424-DENV4IC clone was used
for the construction of a DENV4 replicon (DENV4Rep) as
shown in Fig. 1(a) [see Supplementary Fig. S1 (available in
JGV Online) for details].
The DENV4 replicon contains the 59UTR and the first 25
codons of the capsid (C) gene, fused to the ORF of the Rluc
reporter with its own initiation and termination codons.
This region of the C gene contains the 59 conserved
sequence (CS), which interacts with the 39CS1 in the
39UTR (Hahn et al., 1987). Expression of the Rluc reporter
Fig. 1. Characterization of DENV4Rep-WT and -RepGND mutant replicons. (a) Schematic representation of DENV4rep-WT.
Details of the replicon construction are described in Supplementary Fig. S1. (b) Vero cells were transfected with RNAs from
DENV4Rep-WT (black line) and -GND mutant (grey line) replicons. At different times after transfection, Renilla luciferase (Rluc)
activity was measured in extracts of transfected cells, or cells incubated without any RNA transfection (dotted line), as relative
light units (RLU) with a Centro LB 960 luminometer (Berthold Technologies). (c) Immunofluorescence. RNA-transfected Vero
cells were grown on glass coverslips. Detection of viral NS5 protein in DENV4Rep-WT- and DENVRep-GND-transfected cells
at 96 h post-transfection (p.t.) by immunofluorescence using rabbit polyclonal anti-DENV2 NS5 antibodies (M. Ackermann & R.
Padmanabhan, unpublished results) is shown. Details are given in Supplementary Methods (available in JGV Online).
(d) Estimation of viral RNAs by semiquantative RT-PCR. Total RNA was extracted from Vero cells at 96 h p.t. Tenfold dilutions
of RNA from 250 to 0.25 ng were subjected to reverse transcription (RT) at 42 6C. An aliquot of the RT reaction mixture (1 ml)
was used for PCR, using primers from the NS5 or glyceraldehyde-3-phosphate dehydrogenase (GAPDH; control) genes.
Details are given in Supplementary Methods. Untransfected Vero cells were used as a negative control. Each transfection was
performed in triplicate and each experiment was repeated at least three times.
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the Rluc gene is fused to the encephalomyocarditis virus
internal ribosome entry site (IRES) to direct cap-inde-
pendent translation of the long ORF encoding the viral NS
proteins (Fig. 1a). The region downstream from the IRES
contains the C-terminal 37 codons of the viral envelope (E)
gene that is required for proper translocation of NS1 and
other NS proteins into the ER. In addition, we constructed
a DENV4 replicon containing the GDDAGND mutation
in the RdRP gene, which is known to abolish viral RNA
replication (Khromykh et al., 1998; Ribas & Wickner,
1992).
The time course of Rluc expression was studied in Vero
cells. RNAs from DENV4rep wild type (WT) and mutants
were obtained by in vitro transcription (for details, see
Supplementary Methods, available in JGV Online). Vero
cells (approx. 10
6) were transfected with the RNAs
(approx. 3 mg) by electroporation. Cells were plated into
six wells of a 48-well plate for Rluc assays (100 ml per well)
and the rest into a 12-well plate containing 1 ml medium
for RT-PCR.
Transient expression of DENV4rep and DENV4rep-GND
in transfected cells was monitored by Rluc activity assays
with lysates of transfected cells collected at different times
post-transfection (p.t.) (Fig. 1b). The first peak of Rluc
activity occurred at 2 h p.t. due to translation, and then
declined. At 24 h p.t., the Rluc signal from WT DENV4rep
began to increase until it reached a maximum at 96 h p.t.,
due to translation of the replicated viral RNA. However,
for the DENV4rep-GND mutant replicon, the Rluc activity
reached a peak at 2 h p.t. due to translation, but decreased
steadily to background levels due to a deficiency in
replication (Fig. 1b).
Replication of the WT DENV4rep was confirmed by
immunofluorescence assay of NS1 in the WT replicon-
transfected cells at 96 h p.t., but was negative in DENV4rep-
GND- or non-transfected cells (Fig. 1c). Finally, replication
of DENV4rep was confirmed by RT-PCR using primers
specific for the DENV4 NS5 gene at 96 h p.t. Again, a PCR-
amplified product of the expected size was obtained with
DENV4rep but not with the DENV4rep-GND replicon
RNA-transfected cells (Fig. 1d). Taken together, these results
indicated that the DENV4rep RNA is functional and is
suitable to study virus translation and replication by
measuring luciferase activity at 2 and 96 h p.t., respectively.
Temperature-sensitive (ts) mutants of a gene provide a
powerful tool for studying protein function because they
show a marked change in the level or activity of the gene
product when expressed at a non-permissive temperature.
At permissive temperatures, the phenotype of the mutant
is close to that of the WT. For YFV, a ts mutant of NS1
shown to be defective in accumulation of viral RNA at a
Fig. 2. Translation and replication efficiency of
replicons at different temperatures. (a) Vero
cells were transfected with a replicon RNA and
incubated at 35, 37 or 39 6C for 2 h to
determine translation efficiency (upper panel)
or for 96 h to evaluate replication (lower
panel). The designation of each mutant repli-
con by the residue number from the N terminus
of mature NS3 or NS5, as well as in the
polyprotein, is shown in Supplementary Table
S2 (available in JGV Online). Luciferase activity
was measured in extracts of transfected cells;
the values obtained with the WT and mutant
replicons were compared with those obtained
with the GND replicon. Rluc activities (expressed
as RLU) of each group were compared with that
of the WT by using a Mann–Whitney test
(a50.01) (Minitab 15 statistical software); sig-
nificant differences (P,0.001) are indicated by
asterisks. (b) Estimation of viral RNA by RT-PCR
at 96 h p.t. using primers for NS5. RT-PCR
amplification of the GAPDH gene was used as
loading control. Non-transfected Vero cells were
used as negative controls.
Temperature-sensitive mutations of DENV4 NS3 and NS5
http://vir.sgmjournals.org 2715non-permissive temperature revealed a role of this protein
in viral RNA replication (Muylaert et al., 1997). One com-
monly used method to generate ts mutants is by chemical
mutagenesis, followed by screening of a large number of
progeny for identification of a particular phenotype result-
ing from either loss or gain of function. Blaney and
colleagues isolated ts mutants by treatment of DENV4-
infected cells with the mutagen 5-fluorouracil and char-
acterized mutants that exhibited ts phenotypes in both
Vero and HuH-7 cells (Blaney et al., 2001; Hanley et al.,
2002). Several attenuated ts mutations affecting virus
growth at non-permissive temperatures were identified.
However, as some of the ts mutants had substitutions of
multiple residues in NS genes, the mutation causing a ts
phenotype could not be ascribed to a single residue. More-
over, it was not known at what step of the virus life cycle
the ts phenotype was manifested.
Wefocusedoureffortstostudyts mutationsinNS3andNS5,
as these proteins play important roles in virus replication
(Gamarnik, 2010; Miller et al., 2010; Padmanabhan et al.,
2006). To identify mutations of single residues contributing
to the ts phenotypes, six single-residue substitution mutants
of DENV4rep were constructed (see Supplementary Table
S2, available in JGV Online). WT and mutant replicon RNAs
were synthesized by in vitro transcription of linearized
replicon plasmids catalysed by phage SP6 RNA polymerase.
Equal amounts of replicon RNAs were transfected by
electroporation into Vero cells and the transfected cells were
incubated at 35, 37 and 39 uC. Cells were lysed at 2 and 96 h
p.t. and luciferase activities were measured. At 2 h p.t., the
luciferase activities derived from each mutant at different
temperatures did not differ to an appreciable extent from
those obtained from the WT DENV4rep-transfected cells
(Fig. 2a), suggesting that none of the mutations exhibited a ts
phenotype for viral RNA translation. In contrast, the ts
mutations S158P in the NS3 protease (NS3pro) domain at
39 uC and N96I in the NS5 MTase domain at 37 and 39 uC
showed significantly reduced luciferase activity (P,0.001,
Mann–Whitney test) compared with the DENVrep-WT
replicon at 96 h p.t. (Fig. 2a).
To confirm the results from the Rluc activity assays done at
96 h p.t., the levels of replicated viral RNA from the WT
and mutant replicons were determined by semiquantitative
RT-PCR. The results were in good agreement with the Rluc
signals, as seen from the significant reduction of RNA levels
at 37 and 39 uC for the NS5 N96I mutant, as well as for the
two NS3pro mutants, L128F and S158P, at 39 uC (Fig. 2b).
Thus, the results taken together indicate that the single-
residue substitution mutants in the NS3pro domain and
the NS5 MTase domain exhibited ts phenotypes for RNA
synthesis, with no appreciable effect on viral translation.
The NS5 MTase domain catalyses transfer of a -CH3 group
from S-adenosylmethionine to the N7 of the guanosine cap
(N7 MTase) and to the 29-OH of the first 59 nucleotide of
RNA (29-O MTase). The 29-O MTase activity of DENV2
NS5 was first demonstrated using capped and uncapped
short RNAs (GpppACCCCC and
7-MeGpppACCCCC) as
substrates (Egloff et al., 2002). Subsequently, Ray et al.
(2006), using WNV 59-terminal RNA as substrate for a
-CH3 acceptor, revealed that specific nucleotide sequence
and 59 stem–loop structure of the RNA are required for
N7-methylation and that both N7- and 29-O-Me additions
Fig. 3. N7 and 29-O MTase activity assays. N7 and 29-O MTase
assays were done as described previously (Zhou et al., 2007) (see
also Supplementary Methods). The reactions were incubated at
35, 37 and 39 6C for 2 h and stopped by heating at 95 6C for
10 min. The designation of each mutant replicon is as described in
Fig. 2 and Supplementary Table S2. (a) The reaction mixtures were
treated with 1 U nuclease P1 overnight, and analysed on PEI-
cellulose TLC plates using 0.45 M ammonium sulfate. Plates were
dried and radioactivity was detected by autoradiography. (b) 29-O
MTase activity was measured by conversion of m
7GpppA-RNA to
m
7GpppAm-RNA at pH 10 at the indicated temperatures. The
relative activity of N7- and 29-O-methylation is shown at the
bottom of each panel, with the WT activity set at 100%. The
positions of the origins and migrations of the GpppA, m
7GpppA
and m
7GpppAm molecules are indicated on the left side of the
autoradiograms. Results representative of at least three indepen-
dent experiments are presented.
S. L. Alcaraz-Estrada and others
2716 Journal of General Virology 91are sequential reactions catalysed by the NS5 MTase (Dong
et al., 2007; Ray et al., 2006). N7-methylation is essential
for WNV replication, whereas the defect in 29-O-methyl-
ation attenuates the virus (Zhou et al., 2007). We sought to
investigate whether the ts N96I mutation of NS5 affects the
activity of N7 cap- and/or 29-O-methylation. To this end,
the WT and N96I mutant NS5 MTase domains, each with a
His tag at the N terminus, were expressed in a soluble form
in E. coli and the recombinant proteins were purified (data
not shown). The N7 and 29-O MTase activities of these
recombinant proteins were assayed at different tempera-
tures as described previously (Zhou et al., 2007). N7 cap-
methylation, usually evaluated at 22 uC, was reduced
significantly (P,0.001, Mann–Whitney test) in the ts
mutant NS5 MTase domain at 37 and 39 uC, suggesting
that the N96I mutation causes a ts phenotype for NS5
function in N7 MTase activity (Fig. 3a), although the 29-O
MTase was not affected significantly (P50.1, Mann–
Whitney test; Fig. 3b). Further studies are required to
understand the molecular basis of the N96I mutation in
conferring a ts phenotype on DENV4 NS5 function.
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